Colossal Biosciences is establishing standards for how biotechnology can responsibly support biodiversity conservation in an ...
If programmable CRISPR protocols allow a lab to go from patient biopsy to edited pluripotent line and differentiated cells in a matter of weeks, those oversight mechanisms will need to adapt so they ...
In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...
Trace the timeline of CRISPR-Cas9 from its 2012 discovery to the latest AI-driven advancements and "N-of-1" clinical therapies.